By: Nancy Solomon
18 October 2010
NIH-Funded Vaccine Research at SLU Also Examines Mom’s Immune Response
ST. LOUIS – In the wake of the 2009 H1N1 influenza pandemic, the National Institutes of Health has launched a clinical trial that studies the seasonal flu vaccine in pregnant women.
Saint Louis University, one of the Vaccine and Treatment Evaluation Units (VTEUs) funded by the National Institute of Allergy and Infectious Diseases (NIAID), is among several sites located in various parts of the United States that will recruit pregnant women for the study. Saint Louis University’s Center for Vaccine Development will test the safety and measure the body’s immune response, such as antibody response, to this year’s flu vaccine, as well as examine the vaccine’s ability to protect newborn infants.
“The information from this study will help guide scientists as they work to make vaccines that are more effective in protecting pregnant women and their babies,” said Sharon Frey, M.D., clinical director of Saint Louis University’s Center for Vaccine Development who is leading the research at SLU.
Read the entire article here.